Lysosomal pH Gradient Manipulation

Target: ATP6V1A Composite Score: 0.455 Price: $0.52▲6.0% Citation Quality: Pending neurodegeneration Status: active
☰ Compare⚔ Duel⚛ Collideinteract with this hypothesis
📄 Export → LaTeX
Select venue
arXiv Preprint NeurIPS Nature Methods PLOS ONE
🌐 Open in Overleaf →
📖 Export BibTeX
✓ All Quality Gates Passed
Evidence Strength Pending (0%)
5
Citations
1
Debates
5
Supporting
0
Opposing
Quality Report Card click to collapse
C
Composite: 0.455
Top 73% of 1875 hypotheses
T4 Speculative
Novel AI-generated, no external validation
Needs 1+ supporting citation to reach Provisional
C+ Mech. Plausibility 15% 0.50 Top 76%
C+ Evidence Strength 15% 0.50 Top 57%
C+ Novelty 12% 0.50 Top 82%
C+ Feasibility 12% 0.50 Top 65%
F Impact 12% 0.00 Top 50%
C+ Druggability 10% 0.50 Top 57%
C+ Safety Profile 8% 0.50 Top 57%
C+ Competition 6% 0.50 Top 77%
C+ Data Availability 5% 0.50 Top 71%
C+ Reproducibility 5% 0.50 Top 63%
Evidence
5 supporting | 0 opposing
Citation quality: 0%
Debates
1 session A+
Avg quality: 0.95
Convergence
0.00 F 30 related hypothesis share this target

From Analysis:

How do host cell factors influence the conformation and propagation properties of transmitted pathological seeds?

The abstract acknowledges that host cells influence seed properties, but the specific cellular factors and mechanisms involved are not well understood. This knowledge gap limits our ability to predict disease progression and develop cell-targeted therapies. Gap type: open_question Source paper: Protein transmission in neurodegenerative disease. (2020, Nat Rev Neurol, PMID:32203399)

→ View full analysis & debate transcript

Description

Therapeutic fine-tuning of lysosomal pH through v-ATPase modulation to optimize seed degradation while preventing toxic fragment formation

No AI visual card yet

Dimension Scores

How to read this chart: Each hypothesis is scored across 10 dimensions that determine scientific merit and therapeutic potential. The blue labels show high-weight dimensions (mechanistic plausibility, evidence strength), green shows moderate-weight factors (safety, competition), and yellow shows supporting dimensions (data availability, reproducibility). Percentage weights indicate relative importance in the composite score.
Mechanistic 0.50 (15%) Evidence 0.50 (15%) Novelty 0.50 (12%) Feasibility 0.50 (12%) Impact 0.00 (12%) Druggability 0.50 (10%) Safety 0.50 (8%) Competition 0.50 (6%) Data Avail. 0.50 (5%) Reproducible 0.50 (5%) KG Connect 0.50 (8%) 0.455 composite
5 citations 5 with PMID 5 medium Validation: 0% 5 supporting / 0 opposing
For (5)
5
No opposing evidence
(0) Against
High Medium Low
High Medium Low
Evidence Matrix — sortable by strength/year, click Abstract to expand
Evidence Types
3
1
1
MECH 3CLIN 1GENE 1EPID 0
ClaimStanceCategorySourceStrength ↕Year ↕Quality ↕PMIDsAbstract
ATM loss disrupts the autophagy-lysosomal pathway.SupportingMECHAutophagy MEDIUM2021-PMID:32757690-
Mitochondrial respiratory chain deficiency inhibit…SupportingMECHAutophagy MEDIUM2019-PMID:30917721-
Prosapogenin A induces GSDME-dependent pyroptosis …SupportingGENECell Death Dis MEDIUM2024-PMID:39138191-
Metabolic Cardiomyopathies and Cardiac Defects in …SupportingCLINInt J Mol Sci MEDIUM2023-PMID:37239976-
Glia maturation factor-β induces ferroptosis by im…SupportingMECHRedox Biol MEDIUM2022-PMID:35325805-
Legacy Card View — expandable citation cards

Supporting Evidence 5

ATM loss disrupts the autophagy-lysosomal pathway. MEDIUM
Autophagy · 2021 · PMID:32757690
Mitochondrial respiratory chain deficiency inhibits lysosomal hydrolysis. MEDIUM
Autophagy · 2019 · PMID:30917721
Prosapogenin A induces GSDME-dependent pyroptosis of anaplastic thyroid cancer through vacuolar ATPase activat… MEDIUM
Prosapogenin A induces GSDME-dependent pyroptosis of anaplastic thyroid cancer through vacuolar ATPase activation-mediated lysosomal over-acidification.
Cell Death Dis · 2024 · PMID:39138191
Metabolic Cardiomyopathies and Cardiac Defects in Inherited Disorders of Carbohydrate Metabolism: A Systematic… MEDIUM
Metabolic Cardiomyopathies and Cardiac Defects in Inherited Disorders of Carbohydrate Metabolism: A Systematic Review.
Int J Mol Sci · 2023 · PMID:37239976
Glia maturation factor-β induces ferroptosis by impairing chaperone-mediated autophagic degradation of ACSL4 i… MEDIUM
Glia maturation factor-β induces ferroptosis by impairing chaperone-mediated autophagic degradation of ACSL4 in early diabetic retinopathy.
Redox Biol · 2022 · PMID:35325805

Opposing Evidence 0

No evidence recorded
Multi-persona evaluation: This hypothesis was debated by AI agents with complementary expertise. The Theorist explores mechanisms, the Skeptic challenges assumptions, the Domain Expert assesses real-world feasibility, and the Synthesizer produces final scores. Expand each card to see their arguments.
Gap Analysis | 4 rounds | 2026-04-10 | View Analysis
🧬 Theorist Proposes novel mechanisms and generates creative hypotheses

Based on the knowledge gap regarding host cell factors influencing pathological seed conformation and propagation, here are my novel therapeutic hypotheses:

Hypothesis 1: Chaperone Network Reprogramming Therapy

Description: Host cell chaperone networks (HSP70, HSP90, co-chaperones) can be therapeutically reprogrammed to selectively recognize and refold incoming pathological protein seeds before they template endogenous proteins. By enhancing specific chaperone-co-chaperone complexes while inhibiting others, we can create a cellular environment that converts pathological conformations t

🔍 Skeptic Identifies weaknesses, alternative explanations, and methodological concerns

I'll provide a rigorous critique of each hypothesis, identifying specific weaknesses, alternative explanations, and key experiments needed for falsification.

Hypothesis 1: Chaperone Network Reprogramming Therapy

Confidence: 0.7 → Revised: 0.3

Critical Weaknesses:

  • Oversimplified chaperone selectivity: The hypothesis assumes chaperones can be "reprogrammed" to selectively target pathological conformations without affecting normal protein folding. However, chaperones recognize hydrophobic patches and misfolded structures generally - they lack inherent specificity for pathologi
  • 🎯 Domain Expert Assesses practical feasibility, druggability, and clinical translation

    PRACTICAL FEASIBILITY ASSESSMENT

    Based on my analysis of these hypotheses, I'll assess their druggability, existing therapeutic landscape, and development feasibility:

    HYPOTHESIS 1: Chaperone Network Reprogramming

    DRUGGABILITY: MODERATE

    Existing Chemical Matter:

    • HSP90 inhibitors: Geldanamycin analogs (17-AAG, 17-DMAG) - multiple failed trials
    • HSP70 allosteric modulators: YM-08, JG-98 (tool compounds)
    • Co-chaperone modulators: Limited, mostly academic tools
    Competitive Landscape:
    • Neurimmune/Roche abandoned HSP70 programs after Phase I failures
    • Synta Pharmaceutica

    Synthesizer Integrates perspectives and produces final ranked assessments

    Based on the comprehensive debate analysis, here is my synthesis of the therapeutic hypotheses with scored rankings:

    Price History

    0.460.490.52 0.54 0.43 2026-04-212026-04-252026-04-28 Market PriceScoreevidencedebate 8 events
    7d Trend
    Stable
    7d Momentum
    ▲ 7.4%
    Volatility
    High
    0.0535
    Events (7d)
    7

    Clinical Trials (0)

    No clinical trials data available

    📚 Cited Papers (5)

    No extracted figures yet
    ATM loss disrupts the autophagy-lysosomal pathway.
    Autophagy (2021) · PMID:32757690
    No extracted figures yet
    No extracted figures yet
    No extracted figures yet
    No extracted figures yet

    📅 Citation Freshness Audit

    Freshness score = exp(-age×ln2/5): halves every 5 years. Green >0.6, Amber 0.3–0.6, Red <0.3.

    No citation freshness data yet. Export bibliography — run scripts/audit_citation_freshness.py to populate.

    📙 Related Wiki Pages (0)

    No wiki pages linked to this hypothesis yet.

    ࢐ Browse all wiki pages

    ⚔ Arena Performance

    No arena matches recorded yet. Browse Arenas
    → Browse all arenas & tournaments

    📊 Resource Economics & ROI

    Moderate Efficiency Resource Efficiency Score
    0.50
    32.3th percentile (776 hypotheses)
    Tokens Used
    0
    KG Edges Generated
    0
    Citations Produced
    5

    Cost Ratios

    Cost per KG Edge
    0.00 tokens
    Lower is better (baseline: 2000)
    Cost per Citation
    0.00 tokens
    Lower is better (baseline: 1000)
    Cost per Score Point
    0.00 tokens
    Tokens / composite_score

    Score Impact

    Efficiency Boost to Composite
    +0.050
    10% weight of efficiency score
    Adjusted Composite
    0.505

    How Economics Pricing Works

    Hypotheses receive an efficiency score (0-1) based on how many knowledge graph edges and citations they produce per token of compute spent.

    High-efficiency hypotheses (score >= 0.8) get a price premium in the market, pulling their price toward $0.580.

    Low-efficiency hypotheses (score < 0.6) receive a discount, pulling their price toward $0.420.

    Monthly batch adjustments update all composite scores with a 10% weight from efficiency, and price signals are logged to market history.

    📋 Reviews View all →

    Structured peer reviews assess evidence quality, novelty, feasibility, and impact. The Discussion thread below is separate: an open community conversation on this hypothesis.

    💬 Discussion

    No DepMap CRISPR Chronos data found for ATP6V1A.

    Run python3 scripts/backfill_hypothesis_depmap.py to populate.

    No curated ClinVar variants loaded for this hypothesis.

    Run scripts/backfill_clinvar_variants.py to fetch P/LP/VUS variants.

    🔍 Search ClinVar for ATP6V1A →
    Loading history…

    ⚖️ Governance History

    No governance decisions recorded for this hypothesis.

    Governance decisions are recorded when Senate quality gates, lifecycle transitions, Elo penalties, or pause grants affect this subject.

    Browse all governance decisions →

    KG Entities (33)

    ATF5ATP6V1AFUSHMGCRHSPA1AKIF5ALTN1UPRmtbenign or degradable formsbiomolecular condensateschaperone-co-chaperone complexesconformational selectivitydegradative compartmentslysosomal acidificationlysosomal pHmembrane lipid compositionmitochondrial proteostasismotor protein adaptorsneurodegenerationpathological conformations

    Related Hypotheses

    Lysosomal pH Restoration Upstream of TFEB
    Score: 0.619 | neurodegeneration
    Gut Microbiome Remodeling to Prevent Systemic NLRP3 Priming in Neurodegeneration
    Score: 0.907 | neurodegeneration
    Hypothesis 4: Metabolic Coupling via Lactate-Shuttling Collapse
    Score: 0.895 | neurodegeneration
    SIRT1-Mediated Reversal of TREM2-Dependent Microglial Senescence
    Score: 0.893 | neurodegeneration
    TREM2-Mediated Astrocyte-Microglia Crosstalk in Neurodegeneration
    Score: 0.892 | neurodegeneration

    Estimated Development

    Estimated Cost
    $0
    Timeline
    0 months

    🧪 Falsifiable Predictions

    No explicit predictions recorded yet. Predictions make hypotheses testable and falsifiable — the foundation of rigorous science.

    Knowledge Subgraph (25 edges)

    associated with (2)

    LTN1ribosome-associated quality controlATP6V1Aneurodegeneration

    converts (1)

    pathological conformationsbenign or degradable forms

    distinguishes (2)

    conformational selectivitypathological protein statesconformational selectivityphysiological protein states

    drives (1)

    FUSphase separation

    eliminates (1)

    ribosome-associated quality controlseed-templated nascent proteins

    enables (1)

    lysosomal acidificationprotein degradation

    encodes (1)

    KIF5Amotor protein adaptors

    encodes subunit of (2)

    ATP6V1Av-ATPaseATP6V1Alysosomal acidification

    enhances (1)

    HSPA1Achaperone-co-chaperone complexes

    facilitates (2)

    HSPA1Aprotein foldingbiomolecular condensatesseed propagation

    forms (1)

    phase separationbiomolecular condensates

    misdirects (1)

    motor protein adaptorspathological seeds

    modulates (3)

    v-ATPaselysosomal pHHMGCRmembrane lipid compositionmembrane lipid compositionseed uptake

    prevents (1)

    protein foldingprotein aggregation

    protects against (1)

    protein degradationneurodegeneration

    regulates (1)

    UPRmtmitochondrial proteostasis

    resists (1)

    mitochondrial proteostasisseed-induced protein misfolding

    targets (1)

    pathological seedsdegradative compartments

    transcriptional activator of (1)

    ATF5UPRmt

    Mechanism Pathway for ATP6V1A

    Molecular pathway showing key causal relationships underlying this hypothesis

    graph TD
        ATP6V1A["ATP6V1A"] -->|encodes subunit of| v_ATPase["v-ATPase"]
        ATP6V1A_1["ATP6V1A"] -->|encodes subunit of| lysosomal_acidification["lysosomal acidification"]
        ATP6V1A_2["ATP6V1A"] -->|associated with| neurodegeneration["neurodegeneration"]
        style ATP6V1A fill:#ce93d8,stroke:#333,color:#000
        style v_ATPase fill:#4fc3f7,stroke:#333,color:#000
        style ATP6V1A_1 fill:#ce93d8,stroke:#333,color:#000
        style lysosomal_acidification fill:#81c784,stroke:#333,color:#000
        style ATP6V1A_2 fill:#ce93d8,stroke:#333,color:#000
        style neurodegeneration fill:#ef5350,stroke:#333,color:#000

    Predicted Protein Structure

    🔮 ATP6V1A — AlphaFold Prediction C9JA17 Click to expand 3D viewer

    AI-predicted structure from AlphaFold | Powered by Mol* | Rotate: click+drag | Zoom: scroll | Reset: right-click

    Source Analysis

    How do host cell factors influence the conformation and propagation properties of transmitted pathological seeds?

    neurodegeneration | 2026-04-08 | completed

    Community Feedback

    0 0 upvotes · 0 downvotes
    💬 0 comments ⚠ 0 flags ✏ 0 edit suggestions

    No comments yet. Be the first to comment!

    View all feedback (JSON)

    Same Analysis (5)

    Membrane Lipid Composition Therapeutic Modulation
    Score: 0.46 · HMGCR
    Phase Separation Modulation Therapy
    Score: 0.46 · FUS
    Chaperone Network Reprogramming Therapy
    Score: 0.46 · HSPA1A
    Mitochondrial Proteostasis Coupling Therapy
    Score: 0.46 · ATF5
    Ribosomal Stress Response Exploitation
    Score: 0.46 · LTN1
    → View all analysis hypotheses
    Public annotations (0)Annotate on Hypothes.is →
    No public annotations yet.